Petmed Express Free Cash Flow (FCF) History (PETS)
Petmed Express reported −$33.0M in free cash flow for fiscal 2026, a decrease of $32.6M from the previous fiscal year, with a free cash flow margin of −18.44%.
View full Petmed Express company overviewPetmed Express free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-03-31 | −$33.0M | −$32.6M | — | −18.44% |
| 2025 | 2025-03-31 | −$395,000 | −$201,000 | — | −0.17% |
| 2024 | 2024-03-31 | −$194,000 | −$22.7M | — | −0.07% |
| 2023 | 2023-03-31 | $22.5M | $5.8M | +34.62% | +9.11% |
| 2022 | 2022-03-31 | $16.7M | −$20.9M | −55.51% | +6.15% |
| 2021 | 2021-03-31 | $37.6M | $1.1M | +3.04% | +12.40% |
| 2020 | 2020-03-31 | $36.5M | −$8.0M | −17.94% | +12.86% |
| 2019 | 2019-03-31 | $44.5M | $7.8M | +21.38% | +15.71% |
| 2018 | 2018-03-31 | $36.7M | $76,000 | +0.21% | +13.40% |
| 2017 | 2017-03-31 | $36.6M | $35.7M | +3865.33% | +14.69% |
| 2016 | 2016-03-31 | $923,000 | −$30.2M | −97.03% | +0.39% |
| 2015 | 2015-03-31 | $31.1M | $17.7M | +131.22% | — |
| 2014 | 2014-03-31 | $13.5M | $797,000 | +6.29% | — |
| 2013 | 2013-03-31 | $12.7M | −$7.0M | −35.67% | — |
| 2012 | 2012-03-31 | $19.7M | −$9.8M | −33.13% | — |
| 2011 | 2011-03-31 | $29.4M | $2.8M | +10.52% | — |
| 2010 | 2010-03-31 | $26.6M | — | — | — |
Petmed Express quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q1 2027 | 2026-06-30 | −$8.3M | $5.2M | — | −20.30% |
| Q4 2026 | 2026-03-31 | −$5.5M | −$10.1M | — | −12.76% |
| Q3 2026 | 2025-12-31 | −$9.2M | −$7.3M | — | −22.69% |
| Q2 2026 | 2025-09-30 | −$4.8M | −$10.9M | — | −10.82% |
| Q1 2026 | 2025-06-30 | −$13.6M | −$4.4M | — | −26.50% |
| Q4 2025 | 2025-03-31 | $4.6M | −$1.3M | −21.28% | +9.11% |
| Q3 2025 | 2024-12-31 | −$1.9M | $1.8M | — | −3.74% |
| Q2 2025 | 2024-09-30 | $6.1M | $7.9M | — | +10.55% |
| Q1 2025 | 2024-06-30 | −$9.2M | −$8.6M | — | −13.90% |
| Q4 2024 | 2024-03-31 | $5.9M | −$1.9M | −24.62% | +9.87% |
| Q3 2024 | 2023-12-31 | −$3.7M | −$15.7M | — | −5.69% |
| Q2 2024 | 2023-09-30 | −$1.8M | $865,000 | — | −2.48% |
| Q1 2024 | 2023-06-30 | −$591,000 | −$6.0M | — | −0.76% |
| Q4 2023 | 2023-03-31 | $7.8M | −$438,000 | −5.32% | +14.59% |
| Q3 2023 | 2022-12-31 | $12.0M | $3.6M | +42.39% | +20.35% |
| Q2 2023 | 2022-09-30 | −$2.6M | −$3.6M | — | −4.02% |
| Q1 2023 | 2022-06-30 | $5.4M | $6.3M | — | +7.71% |
| Q4 2022 | 2022-03-31 | $8.2M | −$9.6M | −53.93% | +12.69% |
| Q3 2022 | 2021-12-31 | $8.4M | $2.6M | +45.46% | +13.85% |
| Q2 2022 | 2021-09-30 | $1.0M | −$24.3M | −96.05% | +1.49% |
| Q1 2022 | 2021-06-30 | −$899,000 | $10.4M | — | −1.13% |
| Q4 2021 | 2021-03-31 | $17.9M | $1.1M | +6.45% | +27.05% |
| Q3 2021 | 2020-12-31 | $5.8M | $2.9M | +101.29% | +8.78% |
| Q2 2021 | 2020-09-30 | $25.3M | $8.3M | +48.77% | +33.59% |
| Q1 2021 | 2020-06-30 | −$11.3M | −$11.2M | — | −11.79% |
| Q4 2020 | 2020-03-31 | $16.8M | $3.8M | +29.09% | +22.59% |
| Q3 2020 | 2019-12-31 | $2.9M | −$8.7M | −75.16% | +4.80% |
| Q2 2020 | 2019-09-30 | $17.0M | $18.8M | — | +24.36% |
| Q1 2020 | 2019-06-30 | −$156,000 | −$21.9M | — | −0.20% |
| Q4 2019 | 2019-03-31 | $13.0M | $10.9M | +520.53% | +20.13% |
| Q3 2019 | 2018-12-31 | $11.6M | −$5.1M | −30.44% | +19.25% |
| Q2 2019 | 2018-09-30 | −$1.8M | −$5.9M | — | −2.49% |
| Q1 2019 | 2018-06-30 | $21.7M | $7.9M | +56.85% | +24.86% |
| Q4 2018 | 2018-03-31 | $2.1M | −$12.7M | −85.86% | +3.11% |
| Q3 2018 | 2017-12-31 | $16.6M | $16.8M | — | +27.66% |
| Q2 2018 | 2017-09-30 | $4.1M | −$7.3M | −64.11% | +6.15% |
| Q1 2018 | 2017-06-30 | $13.9M | $3.4M | +31.91% | +17.39% |
| Q4 2017 | 2017-03-31 | $14.8M | $36.4M | — | — |
| Q3 2017 | 2016-12-31 | −$144,000 | −$8.7M | — | — |
| Q2 2017 | 2016-09-30 | $11.4M | $8.3M | +260.95% | — |
| Q1 2017 | 2016-06-30 | $10.5M | −$199,000 | −1.86% | — |
| Q4 2016 | 2016-03-31 | −$21.5M | −$23.5M | — | — |
| Q3 2016 | 2015-12-31 | $8.6M | $2.7M | +45.33% | — |
| Q2 2016 | 2015-09-30 | $3.2M | −$5.8M | −64.70% | — |
| Q1 2016 | 2015-06-30 | $10.7M | −$3.5M | −24.91% | — |
| Q4 2015 | 2015-03-31 | $2.0M | $6.2M | — | — |
| Q3 2015 | 2014-12-31 | $5.9M | $12.6M | — | — |
| Q2 2015 | 2014-09-30 | $9.0M | $4.5M | +99.89% | — |
| Q1 2015 | 2014-06-30 | $14.3M | −$5.6M | −28.17% | — |
| Q4 2014 | 2014-03-31 | −$4.2M | $4.5M | — | — |
| Q3 2014 | 2013-12-31 | −$6.7M | −$12.6M | — | — |
| Q2 2014 | 2013-09-30 | $4.5M | $2.6M | +142.62% | — |
| Q1 2014 | 2013-06-30 | $19.8M | $6.2M | +45.95% | — |
| Q4 2013 | 2013-03-31 | −$8.6M | −$15.2M | — | — |
| Q3 2013 | 2012-12-31 | $5.9M | $8.7M | — | — |
| Q2 2013 | 2012-09-30 | $1.8M | −$5.6M | −75.15% | — |
| Q1 2013 | 2012-06-30 | $13.6M | $5.1M | +60.65% | — |
| Q4 2012 | 2012-03-31 | $6.6M | $2.0M | +43.00% | — |
| Q3 2012 | 2011-12-31 | −$2.8M | −$29.1M | — | — |
| Q2 2012 | 2011-09-30 | $7.4M | — | — | — |
| Q1 2012 | 2011-06-30 | $8.5M | — | — | — |
| Q3 2011 | 2010-12-31 | $4.6M | — | — | — |
| Q1 2011 | 2010-06-30 | $26.3M | — | — | — |
Petmed Express free cash flow growth trends
Over the last five reported fiscal years, free cash flow declined from $37.6M to −$33.0M, a net decrease of $70.7M. Petmed Express's latest reported quarter, Q1 2027, generated −$8.3M in free cash flow, an increase of $5.2M year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Petmed Express filings at SEC.gov ↗